TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo July 22, 2022 Amro Albanna Chief Executive Officer Aditxt, Inc. 737 N. Fifth Street, Suite 200 Richmond, VA 23219 Re: Aditxt, Inc. Registration Statement on Form S-1 Filed July 18, 2022 File No. 333-266183 Dear Mr. Albanna: We have limited our review of your registration statement to those issues we have addressed in our comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to the comment, we may have additional comments. Registration Statement on Form S-1 Cover Page 1. We note your disclosure that your offering of common shares will be at an "assumed purchase price." Please revise to state the price of the securities to the public and clarify whether it will be fixed for the duration of the offering. If you are not able to state a price, explain the method by which the price is to be determined. Refer to Instruction 2 to Item 501(b)(3) of Regulation S-K for guidance. Also please revise to specify the date when this best-efforts offering will terminate. Refer to Item 501(b)(8) of Regulation S-K. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate Amro Albanna Aditxt, Inc. July 22, 2022 Page 2 time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Chris Edwards at 202-551-6761 or Joe McCann at 202-551-6262 with any questions. Sincerely, FirstName LastNameAmro Albanna Division of Corporation Finance Comapany NameAditxt, Inc. Office of Life Sciences July 22, 2022 Page 2 cc: Emily A. Mastoloni, Esq. FirstName LastName